Showing 8,701 - 8,720 results of 74,781 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((a decrease) OR (nn decrease)) ))', query time: 1.03s Refine Results
  1. 8701
  2. 8702
  3. 8703
  4. 8704
  5. 8705
  6. 8706
  7. 8707

    Mortality dataset used in analysis. by Samuel Sendagala (21417164)

    Published 2025
    “…<div><p>Background</p><p>Uganda reported a significant reduction in the mortality rate of children under 5 years of age, from 146/1,000 live births in 2000–42/1,000 live births in 2021. …”
  8. 8708

    Differences in abundance of non-lipid molecules in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice. by Ian R. Phillips (5074121)

    Published 2023
    “…Red dots are non-lipids that are significantly increased or decreased in <i>Fmo5</i><sup><i>-/-</i></sup> mice with a -log<sub>10</sub> <i>q</i> above 1.301 (<i>q</i> <0.05) (grey line). …”
  9. 8709
  10. 8710
  11. 8711
  12. 8712
  13. 8713
  14. 8714

    Differences in abundance of lipid molecules in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice. by Ian R. Phillips (5074121)

    Published 2023
    “…Red dots are lipids that are significantly increased or decreased in <i>Fmo5</i><sup><i>-/-</i></sup> mice with a -log<sub>10</sub> <i>q</i> above 1.301 (<i>q</i> <0.05) (grey line). …”
  15. 8715
  16. 8716
  17. 8717

    Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis by Carlos Aravena (787791)

    Published 2015
    “…The meta-analysis resulted in a decrease in all cause-mortality (RR 0.52 IC 0.32–0.88) and IPF related mortality (RR 0.32 IC 0.14–0.75); other outcomes evaluated were worsening of IPF (RR 0.64 IC 0.50–0.83) and acute exacerbation (RR: 0.72 IC 0.30–1.66 respectively). …”
  18. 8718
  19. 8719
  20. 8720

    Image 5_Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024).tif by Ao Shen (127290)

    Published 2025
    “…R-bibliometrix, VOSviewer, and CiteSpace were employed to conduct quantitative analysis and visualize research trends and factors influencing QOL. Complementarily, a cross-sectional study of 117 cervical cancer patients assessed symptom prevalence via CTCAE v5.0, with symptom clusters identified.…”